Citius Oncology (CTOR) Selling, General & Administrative (2023 - 2026)
Powered by 
Analysis
Citius Oncology (CTOR) Selling, General & Administrative (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 165.53 Mn |
| 10 | Citius Oncology | 101.41 Mn | 101.41 Mn | 1.00 Mn | 4.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.22 Mn |
| Mar 31, 2026 | 23.63 Mn |
| Dec 31, 2025 | 2.86 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.88 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Dec 31, 2024 | 3.32 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 768,931.00 |
| Jun 30, 2023 | 199,554.00 |
| Mar 31, 2023 | 147,922.00 |